"Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC). It is under investigation for the treatment of HepatoCellular Carcinoma. . Reference standards of Brivanib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => Brivanib - API Standards [catalogue_number] => PA 02 45000 [category_ids] => ,69,78,70,82,89, [chemical_name] => [weight] => 370.38 [form] => C19H19FN4O3 [cas] => 649735-46-6 [pslug] => 649735-46-6-brivanib-api-pa0245000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 02 45000
CAS :
Molecular Formula : C19H19FN4O3
Molecular Weight : 370.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....